✦ LIBER ✦

Treatment of neuroblastoma with131I-metaiodobenzylguanidine: The experience of an Italian study group

✍ Scribed by Bestagno, M. ;Guerra, P. ;Puricelli, G. P. ;Colombo, L. ;Calculli, G.

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 182 KB
Volume: 15
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950150413

No coin nor oath required. For personal study only.

✦ Synopsis

Eight patients affected by neuroblastoma were treated with 18 courses of 131I-meta-iodobenzylguanidine (MIBG). They all had been judged as "nonresponders" to conventional treatments. Six had stage IV disease: of these, five, with massive marrow involvement, had poor results, mainly because of marrow depression; one, whose marrow had been previously purged by chemotherapy, showed a decrease in blood cell counts but not to critical levels, thus allowing repeated treatments and some improvement. Two other cases had stage III disease, without marrow involvement. Both could receive repeated treatments without adverse effects on marrow and circulating blood cells; both could have surgical procedures when a significant neoplastic mass reduction had been induced by MIBG treatments. Almost all patients experienced reduction or disappearing of pain. Treatments were well tolerated.

📜 SIMILAR VOLUMES

Treatment of neuroblastoma with131I-meta

Treatment of neuroblastoma with131I-metaiodobenzylguanidine: Experience of the Münster/Kassel group

✍ Fischer, M. ;Wehinger, H. ;Kraus, C. ;Ritter, J. ;Schröter, W. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

I-131-metaiodobenzylguanidine was used for treatment of neuroblastoma stage IV in three children after surgery and or chemotherapy had failed to be effective. In two of the children with multilocular lesions, after an impressive improvement of clinical symptoms tumor progression was observed. Becaus

Treatment of neuroblastoma with131I-meta

Treatment of neuroblastoma with131I-metaiodobenzylguanidine

✍ Troncone, L. ;Riccardi, R. ;Montemaggi, P. ;Rufini, V. ;Lasorella, A. ;Mastrange 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

Seven patients with neuroblastoma (six children and one adult) were treated with therapeutic doses of high specific activity 131I-metaiodobenzylguanidine (131I-MIBG). Six patients were in stage IV and unresponsive to conventional treatment. One patient, in stage III, was treated at diagnosis, an app

Position paper: Role of131I-metaiodobenz

Position paper: Role of131I-metaiodobenzylguanidine in the treatment of neuroblastoma

✍ Mastrangelo, Renato; Tornesello, Assunta; Mastrangelo, Stefano 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Background. Standard chemo-radiotherapy methods for the treatment of children with advanced neuroblastoma (NBL) including bone marrow transplant approaches have been disappointing. These poor results can be ascribed to the evolution of residual drug-resistant cell populations. Curative attempts shou

Primary hypothyroidism as a consequence

Primary hypothyroidism as a consequence of 131 -I-metaiodobenzylguanidine treatment for children with neuroblastoma

✍ Paolo Picco; Alberto Garaventa; Franco Claudiani; Marco Gattorno; Bruno De Berna 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Editorial: The treatment of neuroblastom

Editorial: The treatment of neuroblastoma with131I-MIBG

✍ Mastrangelo, Renato 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Treatment of advanced neuroblastoma with

Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the study group of Japan

✍ Shigenori Sawaguchi; Michio Kaneko; Jun-Ichi Uchino; Takeo Takeda; Makoto Iwafuc 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB